Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and ...

A collaboration will test whether changes in a person’s voice can help detect multiple sclerosis, potentially enabling a ...

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...

Continued treatment with Briumvi provided sustained clinical benefits to patients with relapsing MS, particularly when ...

After struggling during seasons when MS took center stage, columnist Ahna Crum is enjoying the quieter days where it's only ...

MS pain is the uninvited guest you can't turn away, columnist Desiree Lama writes. Listening to your body is the key to ...

Immunic raised funds to support Phase 3 clinical trials of vidofludimus calcium for MS and transition into a commercial-stage company.

A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.

TG Therapeutics is gearing up for a new clinical trial, dubbed ULTIMATE, to test Briumvi in children and adolescents with ...

In people with early MS, diet may correlate with biological aging and the development of disease-related disability, study ...

Tolebrutinib failed to lower disability progression risk in primary progressive MS in a Phase 3 trial, with data shown at ...

Some MS diets may help lower inflammation marker levels, but evidence from clinical trials remains limited, according to a new review paper.